23andMe Holding Co.
NASDAQ:ME
23andMe Holding Co.
NASDAQ:ME
Price:
0.5023 USD
-0.46%
Market Closed
Updated:
May 4, 2024
23andMe Holding Co.
Cash from Operating Activities
|
23andMe Holding Co.
Cash from Operating Activities Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
23andMe Holding Co.
NASDAQ:ME
|
Cash from Operating Activities
-$165.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Operating Activities
$1.3B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Operating Activities
$10.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Operating Activities
$11.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
26%
|
CAGR 10-Years
32%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Operating Activities
$1.2B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
See Also
What is 23andMe Holding Co.'s Cash from Operating Activities?
Cash from Operating Activities
-165.4m
USD
-165.4m
USD
Based on the financial report for Mar 31, 2023, 23andMe Holding Co.'s Cash from Operating Activities amounts to -165.4m USD.
What is 23andMe Holding Co.'s Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
4%
4%
Over the last year, the Cash from Operating Activities growth was 1%. The average annual Cash from Operating Activities growth rates for 23andMe Holding Co. have been 4% over the past three years .
You don't have any saved screeners yet
